NCT06477484Completed
Blood Biomarkers for Screening of Alzheimer's Disease
Blood-based Biomarkers for Early Alzheimer's Disease Screening
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Brief summary (registry, in English)
The goal of this observational study is to estimate the screen performance of blood biomarkers of interest (Aβ40 and Aβ42, P-Tau181, P-Tau217, GFAP and NfL) in patients with Alzheimer's disease (AD), mild cognitive impairment due to AD, and cognitively normal individuals. The main questions it aims to answer are: * to identify core blood biomarker suitable for early screening of AD. * to establish a comprehensive model for the early identification of AD.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 180 (actual)
- First submitted
- 6 Jun 2024
- Start date
- Jun 2024
- Primary completion date
- Mar 2026
- Lead sponsor
- Peking University First Hospital
- Diseases
- Alzheimer disease
- NCT number
- NCT06477484
What you commit to
- Study type: Observational
- Participants enrolled: 180
- From Jun 2024 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The presence of other disorders that can cause cognitive impairment;
Other
- Unable to cooperate with the completion of cognitive assessment;
- Refusal to draw blood.
Who the study is looking for
- Age ≥ 50 years;
- AD (meets the 2011 NIA-AA AD diagnostic criteria), or MCI (meets the 2004 Peterson MCI diagnostic criteria), or cognitively normal subjects;
- Signed informed consent form.
Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University First Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.